Minoru Sasano

1.1k total citations
48 papers, 918 citations indexed

About

Minoru Sasano is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Minoru Sasano has authored 48 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 12 papers in Molecular Biology and 12 papers in Rheumatology. Recurrent topics in Minoru Sasano's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Immune Cell Function and Interaction (7 papers) and Cell Adhesion Molecules Research (7 papers). Minoru Sasano is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Immune Cell Function and Interaction (7 papers) and Cell Adhesion Molecules Research (7 papers). Minoru Sasano collaborates with scholars based in Japan, United States and Czechia. Minoru Sasano's co-authors include Kazuhiko Inoue, GJ Silverman, Hiroyuki Aono, Makoto Goto, Nobuyuki Miyasaka, Makoto Goto, Kazuto Sato, Kusuki Nishioka, Susan B. Wormsley and Gregg J. Silverman and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Minoru Sasano

47 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minoru Sasano Japan 15 317 287 234 187 129 48 918
Curtis C. Maier United States 15 352 1.1× 88 0.3× 274 1.2× 211 1.1× 129 1.0× 31 778
Denise Gretener Switzerland 13 554 1.7× 119 0.4× 532 2.3× 79 0.4× 217 1.7× 15 1.3k
Claus Haase Denmark 20 485 1.5× 107 0.4× 201 0.9× 52 0.3× 101 0.8× 32 897
Zhenrui Shi China 16 414 1.3× 195 0.7× 242 1.0× 79 0.4× 158 1.2× 47 898
Takeru Yoshimura Japan 19 649 2.0× 209 0.7× 329 1.4× 290 1.6× 275 2.1× 36 1.7k
Carla A. Martin United States 17 901 2.8× 143 0.5× 340 1.5× 117 0.6× 209 1.6× 29 1.4k
M Feldmann United Kingdom 14 203 0.6× 194 0.7× 145 0.6× 61 0.3× 94 0.7× 35 662
D. Butler United Kingdom 12 400 1.3× 371 1.3× 228 1.0× 171 0.9× 281 2.2× 19 1.0k
Eduardo Martínez-Soria Switzerland 15 802 2.5× 113 0.4× 238 1.0× 147 0.8× 197 1.5× 21 1.3k
Jun‐ichi Kashiwakura Japan 19 801 2.5× 274 1.0× 221 0.9× 63 0.3× 128 1.0× 65 1.2k

Countries citing papers authored by Minoru Sasano

Since Specialization
Citations

This map shows the geographic impact of Minoru Sasano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minoru Sasano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minoru Sasano more than expected).

Fields of papers citing papers by Minoru Sasano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minoru Sasano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minoru Sasano. The network helps show where Minoru Sasano may publish in the future.

Co-authorship network of co-authors of Minoru Sasano

This figure shows the co-authorship network connecting the top 25 collaborators of Minoru Sasano. A scholar is included among the top collaborators of Minoru Sasano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minoru Sasano. Minoru Sasano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsuji, Fumio, et al.. (2012). Bucillamine inhibits CD40-mediated Akt activation and antibody production in mouse B‐cell lymphoma. International Immunopharmacology. 14(1). 47–53.
2.
Tsuji, Fumio, Taeko Hata, Minoru Narita, et al.. (2011). The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain. European Journal of Pharmacology. 671(1-3). 53–60. 10 indexed citations
3.
Tsuji, Fumio, Masaaki Murai, Kenji Oki, et al.. (2010). Effects of SA13353, a Transient Receptor Potential Vanilloid 1 Agonist, on Leukocyte Infiltration in Lipopolysaccharide-Induced Acute Lung Injury and Ovalbumin-Induced Allergic Airway Inflammation. Journal of Pharmacological Sciences. 112(4). 487–490. 20 indexed citations
4.
Odani‐Kawabata, Noriko, Osamu Katsuta, Hiroshi Nakamura, et al.. (2010). ARG098, a novel anti-human Fas antibody, suppresses synovial hyperplasia and prevents cartilage destruction in a severe combined immunodeficient-HuRAg mouse model. BMC Musculoskeletal Disorders. 11(1). 221–221. 9 indexed citations
5.
6.
Tsuji, Fumio, et al.. (2007). Bucillamine mechanism inhibiting IL-1β-induced VEGF production from fibroblast-like synoviocytes. International Immunopharmacology. 7(12). 1569–1576. 14 indexed citations
7.
Silverman, Gregg J., Minoru Sasano, & Susan B. Wormsley. (1993). The Variable-Region Specificity of Bacterial Fab-Binding Proteins: The Search for B-Cell Superantigens. 2(1). 17–32. 8 indexed citations
8.
Goto, Makoto, et al.. (1992). Constitutive production of angiotensin converting enzyme from rheumatoid nodule cells under serum free conditions.. Annals of the Rheumatic Diseases. 51(6). 741–742. 16 indexed citations
9.
10.
Okamoto, Masahiro, Minoru Sasano, Makoto Goto, et al.. (1991). Suppressive effect of anti-rheumatic drugs on interleukin-1β release from human peripheral blood monocytes. International Journal of Immunopharmacology. 13(1). 39–43. 8 indexed citations
11.
Sasano, Minoru, et al.. (1991). Induction of Cytotoxic Cell Activities by a Novel Cyclic Disulfide Compound, SA3443 in vivo. Immunopharmacology and Immunotoxicology. 13(1-2). 121–133. 4 indexed citations
12.
Sasano, Minoru, Makoto Goto, & K Nishioka. (1990). Modulatory effect of bucillamine (SA96) on interleukin-1-and/or-2-induced proliferation of T lymphocytes. Inflammation Research. 31(3-4). 285–289. 1 indexed citations
13.
Goto, Masamichi, Masahiro Okamoto, Minoru Sasano, et al.. (1990). Adherent synovial cells from nonrheumatoid arthritis do not release interleukin 1 beta and prostaglandin E2 spontaneously in longterm culture.. PubMed. 17(10). 1299–302. 9 indexed citations
14.
Sasano, Minoru, Makoto Goto, & K Nishioka. (1990). Production of prostaglandin E2 induced by histamine by cloned rheumatoid synovial cells.. Annals of the Rheumatic Diseases. 49(7). 504–506. 3 indexed citations
15.
Goto, Makoto, Minoru Sasano, & Kusuki Nishioka. (1989). Decrease in disease activity and concomitant increase in the percentage of peripheral blood suppressor T-cells in rheumatoid arthritis by a newly synthesized slow-acting anti-rheumatic drug (Bucillamine). International Journal of Immunopharmacology. 11(4). 327–331. 12 indexed citations
16.
Sasano, Minoru, et al.. (1989). A Role of Interleukin-1 (IL-1) in Crystal-Induced Arthritis. Advances in experimental medicine and biology. 253A. 219–224. 2 indexed citations
17.
Miyasaka, Nobuyuki, Kazuto Sato, Makoto Goto, et al.. (1988). Augmented interleukin‐1 production and hla–dr expression in the synovium of rheumatoid arthritis patients. Arthritis & Rheumatism. 31(4). 480–486. 190 indexed citations
18.
Goto, Makoto, Terumasa Miyamoto, Minoru Sasano, et al.. (1988). Stimulation of interleukin‐1α and interleukin‐1β release from human monocytes by cyanogen bromide peptides of type ii collagen. Arthritis & Rheumatism. 31(12). 1508–1514. 22 indexed citations
19.
20.
Yamamoto, Itaru, Hitoshi Ohmori, & Minoru Sasano. (1981). CCA: : An immunopharmacological profile. Ensho. 1(2). 281–286. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Curtis C. Maier Breakdown of academic impact, for papers by Denise Gretener Breakdown of academic impact, for papers by Claus Haase Breakdown of academic impact, for papers by Zhenrui Shi Breakdown of academic impact, for papers by Takeru Yoshimura Breakdown of academic impact, for papers by Carla A. Martin Breakdown of academic impact, for papers by M Feldmann Breakdown of academic impact, for papers by D. Butler Breakdown of academic impact, for papers by Eduardo Martínez-Soria Breakdown of academic impact, for papers by Jun‐ichi Kashiwakura
Rankless by CCL
2026